Previous 10 | Next 10 |
HOUSTON, April 29, 2020 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biotechnology company targeting cancers caused by dysregulated gene expression, today announced that its Board of Directors has unveiled nominations and updates to the Board in advanc...
Right Now These Penny Stocks Can Be Bought For Less Than $1 Penny stocks are traditionally known for their low prices. The standard definition of a penny stock is an equity trading below $5. That’s the penny stock definition according to the Securities and Exchange Commission. Howev...
FibroGen (NASDAQ: FGEN ) initiated with Neutral rating and $45 (10% upside) price target at Bank of America. More news on: FibroGen, Inc., Salarius Pharmaceuticals, Inc., Laboratory Corporation of America Holdings, Healthcare stocks news, Stocks on the move, , Read more ...
Salarius Pharmaceuticals (NASDAQ: SLRX ): FY GAAP EPS of -$2.12 misses by $0.14 . More news on: Salarius Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
Seclidemstat Achieves Dose-Escalation Milestone in Phase 1/2 Ewing Sarcoma Clinical Trial Sixth Level Dosing Cohort Now Proceeding; On Track To Report Topline Data in 2020 HOUSTON, March 23, 2020 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-sta...
The following slide deck was published by Salarius Pharmaceuticals, Inc. in conjunction with this Read more ...
HOUSTON, Feb. 11, 2020 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage oncology company targeting cancers caused by dysregulated gene expression, today announced the closing of its previously announced underwritten public offering, with total gross procee...
HOUSTON, Feb. 10, 2020 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biotechnology company targeting cancers caused by mis-regulated gene expression, announced today that its chief executive officer, David Arthur, will present at the Noble Capital Marke...
Gainers: Benitec Biopharma (NASDAQ: BNTC ) +51% . More news on: Benitec Biopharma Limited, Assertio Therapeutics, Inc., Ocwen Financial Corporation, Stocks on the move, , Read more ...
Thinly traded nano cap Salarius Pharmaceuticals (NASDAQ: SLRX ) craters 53% premarket on robust volume in reaction to its public offering of ~7.1M Class A Units at $1.15 and ~1.2M Class B Units at $1.15. More news on: Salarius Pharmaceuticals, Inc., Healthcare stocks news, St...
News, Short Squeeze, Breakout and More Instantly...
Salarius Pharmaceuticals Inc. Company Name:
SLRX Stock Symbol:
NASDAQ Market:
Salarius Pharmaceuticals Inc. Website:
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 1.7% to $112.28 on volume of 455,296,152 shares Ford Motor Company (F) fell 18.4% to $11.16 on volume of 256,384,806 shares PROSHARES TRUST (SQQQ) rose 3.4% to $9.37 on volume of 246,885,889 shares Sel...
Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX) is one of today's top gainers. The company's shares have moved 57.21% on the day to $3.37. Salarius Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing epigenetic-based cancer treatments. Its lead candidate is Secli...
A look at the top 10 most actives in the United States Predictive Oncology Inc. (POAI) rose 115.9% to $2.3099 on volume of 63,737,015 shares Selina Hospitality PLC (SLNA) fell 11.2% to $0.0406 on volume of 59,708,638 shares NVIDIA Corporation (NVDA) fell 1.4% to $112.695 on volume of 52,2...